Bwcp LP Sells 1,324 Shares of Axon Enterprise, Inc. (NASDAQ:AXON)

Bwcp LP cut its position in shares of Axon Enterprise, Inc. (NASDAQ:AXON - Free Report) by 4.2% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 29,998 shares of the biotechnology company's stock after selling 1,324 shares during the quarter. Axon Enterprise accounts for 3.8% of Bwcp LP's portfolio, making the stock its 14th largest position. Bwcp LP's holdings in Axon Enterprise were worth $17,828,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. New Wave Wealth Advisors LLC purchased a new stake in shares of Axon Enterprise in the fourth quarter worth approximately $40,000. Y.D. More Investments Ltd bought a new stake in shares of Axon Enterprise during the 4th quarter worth about $45,000. Stonebridge Financial Group LLC bought a new position in shares of Axon Enterprise in the fourth quarter valued at approximately $53,000. GPS Wealth Strategies Group LLC boosted its holdings in Axon Enterprise by 74.1% during the fourth quarter. GPS Wealth Strategies Group LLC now owns 94 shares of the biotechnology company's stock valued at $56,000 after acquiring an additional 40 shares during the period. Finally, Versant Capital Management Inc increased its stake in shares of Axon Enterprise by 4,750.0% in the fourth quarter. Versant Capital Management Inc now owns 97 shares of the biotechnology company's stock worth $58,000 after purchasing an additional 95 shares during the period. 79.08% of the stock is currently owned by institutional investors and hedge funds.

Axon Enterprise Price Performance

Shares of NASDAQ:AXON traded down $6.76 on Monday, hitting $621.40. The stock had a trading volume of 358,083 shares, compared to its average volume of 753,692. The company has a market capitalization of $48.37 billion, a price-to-earnings ratio of 160.57, a price-to-earnings-growth ratio of 5.17 and a beta of 1.24. The firm's 50 day moving average price is $554.17 and its 200-day moving average price is $578.98. The company has a debt-to-equity ratio of 0.32, a quick ratio of 2.63 and a current ratio of 2.96. Axon Enterprise, Inc. has a twelve month low of $273.52 and a twelve month high of $715.99.

Insider Activity at Axon Enterprise

In related news, Director Jeri Williams sold 307 shares of the business's stock in a transaction that occurred on Monday, March 17th. The shares were sold at an average price of $552.72, for a total value of $169,685.04. Following the completion of the transaction, the director now owns 1,627 shares in the company, valued at $899,275.44. The trade was a 15.87 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, CEO Patrick W. Smith sold 10,000 shares of the stock in a transaction on Monday, April 21st. The shares were sold at an average price of $540.99, for a total value of $5,409,900.00. Following the completion of the transaction, the chief executive officer now owns 3,063,982 shares in the company, valued at $1,657,583,622.18. The trade was a 0.33 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 6.10% of the company's stock.

Analyst Upgrades and Downgrades

AXON has been the topic of a number of research analyst reports. The Goldman Sachs Group raised their target price on Axon Enterprise from $500.00 to $700.00 and gave the company a "buy" rating in a report on Monday, January 27th. TD Cowen initiated coverage on shares of Axon Enterprise in a report on Wednesday, January 8th. They issued a "buy" rating and a $700.00 price target for the company. Barclays restated a "hold" rating on shares of Axon Enterprise in a report on Monday, March 10th. Craig Hallum downgraded Axon Enterprise from a "buy" rating to a "cautious" rating in a research report on Monday, March 10th. Finally, Northcoast Research downgraded Axon Enterprise from a "buy" rating to a "neutral" rating in a research report on Wednesday, February 19th. One equities research analyst has rated the stock with a sell rating, two have given a hold rating and nine have issued a buy rating to the stock. Based on data from MarketBeat.com, Axon Enterprise presently has an average rating of "Moderate Buy" and a consensus price target of $626.45.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.